Press releases

Varian Receives FDA 510(k) Clearance for Ethos Therapy

Varian (NYSE: VAR) today announced it has received FDA 510(k) clearance for its Ethos™ therapy, an Adaptive Intelligence™ solution. Ethos therapy is an artificial intelligence (AI)-driven...

Massachusetts General Hospital Selects Varian Radiotherapy Systems for Cancer Center

Varian (NYSE: VAR) today announced it has signed an agreement with Massachusetts General Hospital to provide seven Varian radiotherapy systems and related services for advanced cancer treatment at...

Varian Reports Results for First Quarter of Fiscal Year 2020

First Quarter 2020 Summary Oncology Systems gross orders grew 8% in dollars or 9% in constant currency in the quarter and over the trailing twelve months Total company revenues grew 12% in...

Postagens do blog

InSightive Analytics: Using Data to Transform the Cancer Center at Baton Rouge General

Centerline

With its introduction of the ARIA® oncology information system, Varian made it possible for providers to amass a huge repository o...

Ler mais

Ethos™ Therapy: Intelligent Adaptation Comes to the Clinic

Centerline

Clinicians have long wanted the ability to adapt radiotherapy treatments to changes in patient anatomy over time. Adaptive treatme...

Ler mais

Automation: All Part of the Script for Eclipse

Centerline

The ability to automatically generate treatment plans in Eclipse using scripting can have a major impact on how clinicians conduct...

Ler mais

Image Gallery

Brachytherapy Treatment Planning Systems
Clinac® iX medical linear accelerator, rotating
Ethos_image_StillCam_04.png
Ethos_image_StillCam_04.png